Saturday 19 March 2022

Reuters Global Healthcare: China reports first COVID deaths in more than a year

China reports first COVID deaths in more than a year

Mainland China reported its first COVID-19 deaths in more than a year on Saturday, according to a post on the National Health Commission's website that said two people died in the northeastern region of Jilin.

U.S. FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer.

Ecuador ends COVID limits on gatherings after hitting vaccination goal

Ecuador's president on Friday announced an end to coronavirus limits on public and private gatherings, but the South American country will continue to require foreign visitors to show proof of vaccinations or a negative COVID-19 test.

CDC reports fewer COVID-19 pediatric deaths after data correction

The U.S. Centers for Disease Control and Prevention reported 966,575 deaths from COVID-19 on Friday after it corrected the data earlier this week, which reduced the death tallies in all age-groups, including children.

Wildfires trigger evacuations in West Texas counties

A series of wind-driven wildfires was burning in a sparely populated area of West Texas on Friday, consuming more than 45,000 acres of dry grasslands and forcing the evacuations of some residents from their homes, fire officials said.

Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

U.S. FDA approves Marinus Pharma's drug to treat seizures; shares jump

The U.S. health regulator has approved Marinus Pharmaceuticals Inc's lead drug to treat seizures associated with a rare genetic disorder in patients two years of age and older, the company said on Friday, sending its shares soaring around 36%.

Bristol Myers sues AstraZeneca over cancer-treatment patents

Bristol Myers Squibb Co , in a lawsuit made public on Friday, said AstraZeneca's cancer treatment Imfinzi violates patents related to its blockbuster cancer drug Opdivo.

French HAS health authority recommends second Covid-19 booster jab for older people with health risks

People aged 65 and older with special health risks or conditions should be given the right to receive a second COVID-19 "booster" jab, France's HAS health authority said on Friday.

EU health body recommends free COVID tests, vaccines for Ukrainian refugees

The European Centre for Disease Prevention and Control (ECDC) said on Friday that countries should provide free COVID-19 testing for refugees from Ukraine to avoid outbreaks as more than three million people flee their war-stricken homeland.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study